SCHEMBL698990

SCHEMBL698990

Cc1ccccc1-c1cccnc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
BLM P54132 1/20 0.52
AGER Q15109 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MYC P01106 3/20 0.50
TACR1 P25103 2/20 0.48
KDM5A P29375 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
KDM5B Q9UGL1 1/20 0.48
KMT2A Q03164 1/20 0.46
CYP1A2 P05177 1/20 0.46
LMNA P02545 1/20 0.46
NAPRT Q6XQN6 1/20 0.46
P4HTM Q9NXG6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31265696 1.00 KDM4E (0.52) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL27641163 0.84 IKBKB (0.51) L3MBTL1MAPTTACR1KDM5AKDM4C
SCHEMBL30719725 0.84 KDM4E (0.53) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL14861468 0.83 KDM4E (0.46) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL130171 0.83 KDM4E (0.61) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL29564333 0.83 KDM4E (0.61) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
Potassium SCHEMBL5919173 0.81 KDM4E (0.59) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL5955807 0.81 KDM4E (0.59) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL2270391 0.81 KDM4E (0.59) KDM4EL3MBTL1MAPTALDH1A1CYP3A4
SCHEMBL6586976 0.81 KDM4E (0.59) KDM4EL3MBTL1MAPTALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958521-B Pyrimidin-4-one derivatives and their use in the treatment, alleviation or prevention of viral diseases 弗·哈夫曼-拉罗切有限公司 2016-10-19 CN disclosed
CN-103958475-B Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases F. HOFFMANN-LA ROCHE AG (CH) 2015-11-25 CN disclosed
CN-103958475-A Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 CN disclosed
CN-103958521-A Pyrimidin-4-one derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 CN disclosed
EP-2421850-A1 3 -AZABICYCLO [4.1.0]HEPTANES USED AS OREXIN ANTAGONISTS Glaxo Group Limited (GB) 2012-02-29 EP disclosed
EP-2379550-A1 PIPERIDINE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS Glaxo Group Limited (GB) 2011-10-26 EP disclosed
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed
WO-2010122151-A1 3 -AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-10-28 WO disclosed
WO-2010080478-A1 COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2010-07-15 WO disclosed
WO-2010072722-A1 PIPERIDINE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-07-01 WO disclosed